Soluble HIV-1 envelope glycoprotein (Env) trimers are under active investigation as vaccine candidates in relevant pre-clinical models. Like SOSIPs, the cleavage-independent native flexibly linked (NFL) trimers are faithful mimics of the Env spike. Here, we analyzed multiple new designs to explore alternative modifications, informing tertiary interactions, while maintaining NFL trimer homogeneity and integrity. Accordingly, we performed a proline (P) substitution screen in the gp41 heptad repeat 1 region, identifying other trimer-enhancing Ps, including L555P. This P improved trimer integrity compared to I559P in selected properties. Next, we screened 15 structure-guided potential cysteine pairs in gp140 and found that A501C-L663C (“CC2”) f...
The HIV-1-envelope glycoprotein (Env) is the main target of antigen design for antibody-based prophy...
A successful HIV-1 vaccine will likely need to elicit broadly neutralizing antibodies (bNAbs) that t...
PURPOSE OF REVIEW: To provide an update on the latest developments in the field of HIV-1 antibody-ba...
Soluble HIV-1 envelope glycoprotein (Env) trimers are under active investigation as vaccine candidat...
<p>Soluble HIV-1 envelope glycoprotein (Env) trimers are under active investigation as vaccine candi...
<p>Soluble HIV-1 envelope glycoprotein (Env) trimers are under active investigation as vaccine candi...
<p>Soluble HIV-1 envelope glycoprotein (Env) trimers are under active investigation as vaccine candi...
<p>Soluble HIV-1 envelope glycoprotein (Env) trimers are under active investigation as vaccine candi...
<p>Soluble HIV-1 envelope glycoprotein (Env) trimers are under active investigation as vaccine candi...
<p>Soluble HIV-1 envelope glycoprotein (Env) trimers are under active investigation as vaccine candi...
<p>Soluble HIV-1 envelope glycoprotein (Env) trimers are under active investigation as vaccine candi...
<p>Soluble HIV-1 envelope glycoprotein (Env) trimers are under active investigation as vaccine candi...
Viral glycoproteins mediate entry by pH-activated or receptor-engaged activation and exist in metast...
The production of native-like recombinant versions of the HIV-1 envelope glycoprotein (Env) trimer r...
The trimeric HIV-1 envelope glycoprotein (Env) is critical for host immune recognition and neutraliz...
The HIV-1-envelope glycoprotein (Env) is the main target of antigen design for antibody-based prophy...
A successful HIV-1 vaccine will likely need to elicit broadly neutralizing antibodies (bNAbs) that t...
PURPOSE OF REVIEW: To provide an update on the latest developments in the field of HIV-1 antibody-ba...
Soluble HIV-1 envelope glycoprotein (Env) trimers are under active investigation as vaccine candidat...
<p>Soluble HIV-1 envelope glycoprotein (Env) trimers are under active investigation as vaccine candi...
<p>Soluble HIV-1 envelope glycoprotein (Env) trimers are under active investigation as vaccine candi...
<p>Soluble HIV-1 envelope glycoprotein (Env) trimers are under active investigation as vaccine candi...
<p>Soluble HIV-1 envelope glycoprotein (Env) trimers are under active investigation as vaccine candi...
<p>Soluble HIV-1 envelope glycoprotein (Env) trimers are under active investigation as vaccine candi...
<p>Soluble HIV-1 envelope glycoprotein (Env) trimers are under active investigation as vaccine candi...
<p>Soluble HIV-1 envelope glycoprotein (Env) trimers are under active investigation as vaccine candi...
<p>Soluble HIV-1 envelope glycoprotein (Env) trimers are under active investigation as vaccine candi...
Viral glycoproteins mediate entry by pH-activated or receptor-engaged activation and exist in metast...
The production of native-like recombinant versions of the HIV-1 envelope glycoprotein (Env) trimer r...
The trimeric HIV-1 envelope glycoprotein (Env) is critical for host immune recognition and neutraliz...
The HIV-1-envelope glycoprotein (Env) is the main target of antigen design for antibody-based prophy...
A successful HIV-1 vaccine will likely need to elicit broadly neutralizing antibodies (bNAbs) that t...
PURPOSE OF REVIEW: To provide an update on the latest developments in the field of HIV-1 antibody-ba...